Investors & Media

SEC Filing Details

Document Details

Form
Filing Date
Jan 4, 2018
Document Date
Jan 2, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
bluebird bio, Inc.
Issuer
bluebird bio, Inc.

Media Contacts

Stephanie Fagan

Senior Vice President, Corporate Communications

(201) 572-9581

sfagan@bluebirdbio.com

 

Catherine Falcetti

Senior Director, Corporate Communications

(339) 499-9436

cfalcetti@bluebirdbio.com

 

Investor Contact

Elizabeth Pingpank

Associate Director, Corporate Communications

(617) 914-8736

EPingpank@bluebirdbio.com